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A  decrease  in  parvalbumin-positive  neurons  in the  hippocampus  and  neocortex  of  grt  mice.
An increase  in  somatostatin-positive  neurons  in  the  hippocampus  of  grt mice.
Hypothyroid  neuronal  state  was  recovered  by  T3 treatment  from  postnatal  day  0 to  20.
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a  b  s  t  r  a  c  t
Thyroid  hormone  (TH)  plays  an  important  role  in  brain  development,  and  TH  deﬁciency  during  pregnancy
or  early  postnatal  periods  leads  to  neurological  disorders  such  as cretinism.  Hypothyroidism  reduces  the
number  of parvalbumin  (PV)-positive  interneurons  in the  neocortex  and  hippocampus.  Here  we  used
a  mouse  strain  (growth-retarded;  grt)  that  shows  growth  retardation  and  hypothyroidism  to  examine
whether  somatostatin  (Sst)-positive  interneurons  that  are  generated  from  the  same  pool  of  neural  pro-
genitor  cells  as  PV-positive  cells  are also  altered  by TH  deﬁciency.  The  number  of PV-positive  interneurons
was  signiﬁcantly  decreased  in  the  neocortex  and  hippocampus  of  grt mice  as  compared  with  normal  con-omatostatin
arvalbumin
eocortex
ippocampus
trol  mice.  In contrast  to  the decrease  in  the  number  of PV  neurons,  the  number  of Sst-positive  interneurons
in  grt  mice  was  increased  in the  stratum  oriens  of the  hippocampus  and  the  hilus  of  the  dentate  gyrus,
although  their  number  was  unchanged  in  the neocortex.  These  changes  were  reversed  by triiodothyro-
nine  administration  from  postnatal  day  (PD)  0 to 20.  TH  supplementation  that  was initiated  after  PD21
did  not,  however,  affect  the  number  of  PV-  or  Sst-positive  cells.  These  results  suggest that  during  the  ﬁrst
three postnatal  weeks,  TH  may  be critical  for the  generation  of  subpopulations  of  interneurons.
he A© 2013 T
. IntroductionThe growth-retarded (grt) mouse was ﬁrst reported as a spon-
aneously derived mutant from phenotypically normal siblings of
he Snell’s dwarf mouse (DW/J strain). The difference in weight
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between the normal and grt mice become apparent by 3 weeks
after birth. However, the weight of the grt mice gradually caught
up to that of the normal mice [35]. In grt mice, plasma concentra-
tions of thyroxine (T4) were signiﬁcantly lower, whereas levels of
thyroid-stimulating hormone (TSH) were greatly elevated [30,35].
Exposure of the thyroid glands of +/+ and +/grt mice to TSH in vitro
resulted in the same degree stimulation of free T4 and free T3
release from the glands and cAMP production in the glands, but
these responses were much weaker in grt/grt thyroid glands [14].
These results indicate that the TSH receptors of these mice are unre-
Open access under CC BY-NC-SA license.sponsive to TSH, which likely contributes to the dysfunction of the
thyroid gland in grt mice [14,15]. Recently, the grt phenotype was
shown to be caused by a single missense mutation in the gene
encoding tyrosylprotein sulfotransferase 2 (Tpst2) with a change
-NC-SA license.
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rom C at nucleotide 798 to G, which leads to the replacement of
 highly conserved histidine with glutamine at codon 266 in the
ulfotransferase domain [27]. Impaired tyrosine sulfation of TSH
eceptor molecules by inactivation of TPST2 reduces responsive-
ess to TSH and causes the functional failure of the thyroid in grt
ice [27].
Thyroid hormone (TH) functions in many critical aspects of
rain development, including synaptic formation [22], neuronal
igration [23], and glial myelination [24], and, consequently, TH
eﬁciency causes mental retardation [25]. Interestingly hypothy-
oid rats display a decrease in the number of PV-positive
nterneurons [1], and this phenomenon is reversed by treatment
ith TH [7].
PV- and somatostatin (Sst)-positive progenitor cells are gen-
rated from the medial ganglionic eminence (MGE), tangentially
igrate toward the neocortex and hippocampus, and become
ature GABAergic interneurons after reaching their destination
3,17]. PV-positive interneurons are detected after postnatal day
PD) 7 in the neocortex and hippocampus [2,26,28] and increase
n number during PD14–21 [4]. PV-positive interneurons even-
ually differentiate into large basket cells and chandelier cells
10,16] and are classiﬁed electrophysiologically as fast-spiking cells
11]. Among interneuron subpopulations, Sst-positive interneu-
ons are also generated from the MGE  [34] and are detected at
D0 in the hippocampus, earlier than PV-positive neurons [29]. The
umber of Sst-positive interneurons increases during PD10–15,
nd they mature to become small basket cells and Martinotti
ells, which are regular-spiking and burst-spiking neurons, respec-
ively [12,21]. Circulating T4 and triiodothyronine (T3) levels are
arkedly increased by the second postnatal week in normal mice
5,8], and thus elevation of TH at this stage may  strongly inﬂuence
he normal development of these interneuron subpopulations.
The aim of the present study was to determine whether TH is
ritical for the development of GABAergic interneurons in mice.
e utilized grt mice and investigated the inﬂuence of hypothy-
oidism on the formation of PV- and Sst-positive interneurons, both
f which originate from the MGE.
. Materials and methods
.1. Animals
Mice were maintained under controlled conditions of tempera-
ure (23 ± 1 ◦C), relative humidity (50 ± 5%), and lighting (lights on
8:00–20:00 h) and were given laboratory chow (Labo MR  Breeder;
osan, Yokohama, Japan) and tap water ad libitum. Male mice with
 wild-type phenotype (+/+, +/grt; referred to as “normal”) and grt
grt/grt) male mice were obtained by mating wild type (+/+) or
eterozygous (+/grt) female mice with heterozygous (+/grt) male
ice.
All animal experiments were conducted in accordance with
nternational standards on animal welfare according to the National
nstitutes of Health Guide for the Care and Use of Laboratory Ani-
als, and the Animal Experiment Guidelines of the Institutes for
nimal Experimentation at Tohoku University and Saitama Uni-
ersity.
.2. Hormone treatment
There were two T3 treatments. One group of mice was  injected
ith phosphate-buffered saline (PBS, pH 7.4) or T3 (Sigma–Aldrich
o., St. Louis, MO,  USA) from PD0 to 20, and the other group was
njected with PBS or T3 from PD21 to 27. Normal mice (n = 4) were
njected intraperitoneally with 10 mM PBS (i.e., they did not receive
3 treatment), and grt mice with PBS (n = 4–5) or T3 in PBS (2 g/10 gtters 559 (2014) 111– 116
body weight; n = 4) once every other day. Brains were collected on
the day after the last injection (i.e., a sampling day is at PD21 or
28). The effective dose of T3 in mice was determined according to
a previous study [31].
2.3. Tissue preparation and immunohistochemistry
Mice were deeply anesthetized with sodium pentobarbi-
tal (50 mg/kg) and perfused with 0.9% saline followed by 4%
paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB, pH 7.4). The
brain was post-ﬁxed overnight in 4% PFA, and stored in 30% sucrose
in 0.01 M PB (pH 7.4) at 4 ◦C for 48 h. Thirty-micrometer-thick sec-
tions were cut on a cryostat, and free-ﬂoating sections were rinsed
in 10 mM  PBS (pH 7.4). After being washed with PBS containing
0.3% (w/v) Triton X-100 (PBS-T), sections were incubated for 30 min
with 5% normal horse or goat serum diluted in PBS-T. The sec-
tions were then incubated overnight at 4 ◦C with mouse anti-PV
(1:500; Sigma–Aldrich Co.) or rabbit anti-Sst (1:500; Enzo Life Sci-
ences International, Inc. Plymouth Meeting, PA, USA). After being
washed with PBS-T, the sections were treated with 0.1% H2O2 to
inactivate endogenous peroxidases. After another wash in PBS-T,
the sections were incubated with biotinylated anti-mouse or anti-
rabbit IgG (1:1000; Vector Laboratories, Burlingame, CA, USA) for
2 h at room temperature, rinsed with PBS-T, and incubated with
avidin–biotin complex (ABC; Vector Laboratories) for 1 h at room
temperature. The staining was then visualized by incubating the
sections in 0.05% diaminobenzidine and 0.02% H2O2 in PBS.
2.4. Quantiﬁcation
Thirty-micrometer serial sections from ∼−1.06 to −3.40 mm
caudal to the bregma according to the stereotaxic atlas of Franklin
and Paxinos [13] were cut on a cryostat and preserved in 200 l
cryoprotectant (PBS with 15% sucrose, 30% ethylene glycol solu-
tion) per well. Sections from each animal were analyzed at 210-m
intervals. After immunostaining, microscopic images of these sec-
tions were taken with a CCD camera and processed using Adobe
Photoshop CS6 (Adobe Systems, San Jose, CA, USA). The area of the
hippocampus (the pyramidal cell layer including CA1 to CA4 and
the granular cell layer of the dentate gyrus) and the area of the
whole neocortex (the motor, somatosensory, visual and association
cortex) in each section were measured using ImageJ (National Insti-
tutes of Health, Bethesda, MD,  USA). The density of immunoreactive
cells in each section was calculated by dividing the number of Sst-
or PV-positive cells by the area of the hippocampus or the neocor-
tex. All data were expressed as the mean ± SEM. Comparisons with
control (PBS-treated normal mice) and study groups (PBS-treated
grt mice and T3-treated grt mice) were analyzed with one-way
ANOVA followed by Tukey’s multiple comparison test. P values of
<0.05 were considered statistically signiﬁcant. Statistical analysis
was performed with GraphPad Prism 5 (GraphPad Software Inc.,
San Diego, CA, USA).
3. Results
3.1. Changes in the number of PV-positive cells in the neocortex
and hippocampus of grt mice
PV-positive cells were widely distributed in the neocortex (see
supplementary Fig. 1). Although the cortical area, including the area
∼−1.06 to −3.40 mm caudal to the bregma, contains the motor cor-
tex, somatosensory cortex, visual cortex, and association cortex, the
results of an immunohistochemical study showed no signiﬁcant
differences among the cortical regions. Thus a numerical value of
the neocortex shows changes of the number of cells in the whole
K. Uchida et al. / Neuroscience Letters 559 (2014) 111– 116 113
Fig. 1. PV-positive interneuron density in the neocortex and hippocampus of grt mice. Graphs show the PV neuron density in the neocortex (A, B) and cornus ammonis (C,
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he  mean ± SEM. *P < 0.05 (normal vs. grt), #P < 0.05 (grt vs. grt + T3).
ortex. At PD21, the number of PV-positive cells in the neocor-
ex of grt mice (5.4 ± 2.9 cells/mm2) was 93% lower than that of
ormal mice (76.0 ± 11.8 cells/mm2; Fig. 1A). Injection of grt mice
ith T3 beginning at PD0 (2 g/10 g body weight) signiﬁcantly
ncreased the number of PV-positive cells (80.0 ± 8.09 cells/mm2)
o a number that was equivalent to the basal level in normal mice
Fig. 1A). At PD28, the number of PV-positive cells in grt mice
33.6 ± 6.6 cells/mm2) was 70% lower than that of normal mice
115.8 ± 13.1 cells/mm2), although the number of PV-positive cells
as higher than that at PD21 (Fig. 1A, B). T3 treatment beginning at
D21 had no effect on the number of PV-positive cells in grt mice
50.4 ± 14.2 cells/mm2; Fig. 1B).
In the hippocampus, PV-positive cells were localized mainly in
he pyramidal cell layer of the CA regions and the granular cell layer
f the dentate gyrus (see supplementary Fig. 2). The changes in the
umber of PV-positive cells among the experimental groups were
imilar to those in the neocortex, and the number of PV-positive
ells in the CA regions of grt mice (112.8 ± 9.6 cells/mm2) was 56%
ower than that of normal mice (258.4 ± 11.4 cells/mm2) at PD21
Fig. 1C). Treatment of grt mice with T3 beginning at PD0 signiﬁ-
antly increased the number of PV-positive cells in the CA regions
224.6 ± 18.0 cells/mm2) to a number that was equivalent to the
asal level in normal mice (Fig. 1C). At PD28, the number of PV-
ositive cells in the CA regions of grt mice (108.4 ± 24.2 cells/mm2)he region was  done at PD 21 (A, C, E) and at PD28 (B, D, F). Data were expressed as
was decreased by 53% as compared with that of normal mice
(229.1 ± 25.7 cells/mm2; Fig. 1D). T3 treatment beginning at PD21
had no effect on the number of PV-positive cells in the CA regions of
grt mice (137.9 ± 11.2 cells/mm2; Fig. 1D). In the granular cell layer
of the dentate gyrus, the number of PV-positive cells in grt mice
at PD21 (14.5 ± 3.5 cells/mm2) was 54% lower than that of normal
mice (26.7 ± 1.8 cells/mm2; Fig. 1E). Treatment of grt mice with T3
beginning at PD0 signiﬁcantly increased the number of PV-positive
cells (27.1 ± 2.9 cells/mm2) (Fig. 1E). At PD28, the number of PV-
positive cells in grt mice (20.2 ± 3.4 cells/mm2) was  reduced by
60% as compared with that of normal mice (50.2 ± 10.5 cells/mm2;
Fig. 1F), and the number of PV-positive cells in the dentate gyrus
was slightly higher than that at PD21. T3 treatment beginning at
PD21 had no effect on the number of PV-positive cells in grt mice
(24.2 ± 6.9 cells/mm2; Fig. 1F).
3.2. Changes in the number of Sst-positive cells in the neocortex
and hippocampus of grt mice
Sst-positive cells were widely distributed in the neocortex
(see supplementary Fig. 3) of the grt mice, and this distribu-
tion was indistinguishable from that of normal mice. At PD21,
no signiﬁcant difference was found in the number of Sst-positive
cells in the neocortex among the experimental groups (normal
114 K. Uchida et al. / Neuroscience Letters 559 (2014) 111– 116
Fig. 2. Sst-positive interneuron density in the neocortex and hippocampus of grt mice. Graphs show the Sst neuron density in the neocortex (A, B) and stratum oriens (C,
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ean  ± SEM. *P < 0.05 (normal vs. grt), #P < 0.05 (grt vs. grt + T3).
ice: 39.4 ± 8.0 cells/mm2, grt mice: 55.7 ± 4.2 cells/mm2, grt + T3:
5.5 ± 5.0 cells/mm2; Fig. 2A). At PD28, we found no signiﬁ-
ant difference in the cell number in the neocortex among the
xperimental groups (normal mice: 57.0 ± 8.7 cells/mm2, grt mice:
2.3 ± 1.6 cells/mm2, grt + T3: 63.6 ± 12.8 cells/mm2), and the num-
er of Sst-positive cells in the neocortex was slightly higher than
hat at PD21 (Fig. 2A, B).
In the hippocampus, Sst-positive cells were localized mainly
n the stratum oriens and the hilus of the dentate gyrus; some
ells were scattered in the stratum radiatum and the CA regions
see supplementary Fig. 4). At PD21, the number of Sst-positive
ells in the hilus of the grt mice (155.4 ± 10.8 cells/mm2) was 118%
reater than that of normal mice (71.1 ± 4.8 cells/mm2; Fig. 2C).
reatment of grt mice with T3 beginning at PD0 signiﬁcantly
ecreased the number of Sst-positive cells (84.5 ± 3.9 cells/mm2;
ig. 2C). At PD28, the number of Sst-positive cells in grt mice
172.5 ± 12.8 cells/mm2) was 88% higher than that of normal mice
91.9 ± 10.2 cells/mm2; Fig. 2D). However, T3 treatment begin-
ing at PD21 had no effect on the number of Sst-positive cells
n the hilus of grt mice (137.0 ± 8.9 cells/mm2; Fig. 2D). The
umber of Sst-positive cells in the stratum oriens of grt mice
179.6 ± 11.3 cells/mm2) was 62% higher than that of normal mice
111.0 ± 8.6 cells/mm2) at PD28 (Fig. 2E). Treatment of grt mice
ith T3 beginning at PD0 signiﬁcantly decreased the number ofion was  done at PD 21 (A, C, E) and at PD28 (B, D, F). Data were expressed as the
Sst-positive cells (103.9 ± 11.6 cells/mm2) to a number equiva-
lent to the basal level of normal mice (Fig. 2E). At PD28, the
number of Sst-positive cells in the stratum oriens of grt mice
(192.6 ± 19.5 cells/mm2) was  52% higher than that of normal mice
(126.1 ± 13.9 cells/mm2; Fig. 2F). However, T3 treatment beginning
at PD21 had no effect on the number of Sst-positive cells in grt mice
(165.5 ± 16.8 cells/mm2; Fig. 2F).
4. Discussion
We  demonstrated that TH deﬁciency led to impairment in the
development of parvalbumin- and somatostatin-positive interneu-
rons in the brains of grt mice and that the defect was ameliorated
by exogenous T3 administration during an early postnatal period
(PD0–20).
Goitrogen-induced hypothyroidism induces a decrease in the
number of PV-positive interneurons in the neocortex and hip-
pocampus of the rat [1,7]. The number of PV-positive interneurons
in the rat brain is also decreased in a dose-dependent manner by
treatment with propylthiouracil (PTU) and the lost PV-positive cells
in the hypothyroid brain are restored by treatment with T4 from
PD8 to 14 [7]. Consistent with these studies, our results showed
that the number of PV-positive neurons was reduced in the brains
of grt mice, and their numbers were restored with T3 treatment
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rom PD0–20. Therefore, TH is likely to play an important role in
he development of PV-positive interneurons, at least in rodents. On
he other hand, TH receptor 1 mutant mouse exhibits low afﬁnity
o TH causes a decrease in the number of PV-positive interneurons
32,33]. Therefore TH action through receptor subtype 1 may  play
 critical role in the normal development of GABAergic interneu-
ons.
In addition, we found for the ﬁrst time that the number of Sst-
ositive neurons in the hippocampus was increased in grt mice.
ato et al. reported that the amount of Sst in the hippocampus
nd other brain regions, including the neocortex, of adult rats is
ncreased following treatment with PTU from PD0–19 [9]. The rea-
on for the discrepancy between our observation of no change in
st-positive cells in the neocortex and Kato et al.’s report of an
ncrease in this region is not clear, but it may  partly be a result
f species differences and/or methodological and assay system dif-
erences. However, the changes in the number of Sst-positive cells
n the hippocampus may  be considered TH dependent, because the
ell number in grt mice was restored to the number in normal mice
y treatment with T3. In the present study, the effect of exoge-
ous T3 on the number of PV- and Sst-positive cells in grt mice
as observed only during the ﬁrst three postnatal weeks, consis-
ent with the idea that these interneurons are responsive to TH only
uring the early postnatal stage. Furthermore, although improper
ifferentiation of interneurons is improved by a short-term TH
reatment of 1 week as described elsewhere [7], T3 treatment from
D 21 to 27 had no effect on the number of interneuron subpopula-
ion. Therefore, critical period of the generation of subpopulations
f interneurons is assumed to exist during the ﬁrst three postnatal
eeks.
One possible mechanism by which TH could affect the devel-
pment of interneurons involves bone morphogenetic protein-4
BMP4). Increased expression of BMP4 mRNA occurs in the neocor-
ex during PD7–14, and this term coincides with the appearance
f PV-positive interneurons in the neocortex [20]. In addition,
verexpression of BMP4 induces an increased in the number of PV-
ositive interneurons and a reduction in the number of Sst-positive
nterneurons in the dentate gyrus of the hippocampus [20]. These
esults raise the possibility that BMP4 directly regulates the dif-
erentiation of PV- and Sst-positive interneurons. Interestingly, the
xpression level of BMP4 is markedly decreased in the hypothy-
oid neonatal brain as compared with the euthyroid state, and the
ecrease in BMP4 is restored by TH supplementation [18]. Thus,
e speculate that a reduction in BMP4 signaling caused by TH deﬁ-
iency impairs the differentiation of interneurons. However, such
 simplistic mechanism for the effects of TH activity on the differ-
ntiation of interneuron subpopulations is not likely, because the
ate of change in the PV-positive cell number in grt mice did not
atch that of Sst-positive interneurons. Moreover, although PV-
ositive neurons were markedly decreased in the neocortex of grt
ice, no signiﬁcant change was found in Sst-positive interneurons.
ence, these results suggest that the action of TH may  be unrelated
o regulation of the interneuron cell lineage such as the switch from
V progenitor cells to Sst progenitor cells. Regarding an increase in
st-positive neurons, one possibility is a compensatory action that
ccurs in response to a reduction in PV-positive neurons. Because
st-positive neurons in the hippocampus are increased by bicu-
ulline treatment [19], an increase in Sst-positive neurons may  be
ue to an imbalance in the excitatory and inhibitory systems that
esults from a reduction in PV-positive interneurons.
Normal mice showed a marked transient rise in serum T4 level
t 2 weeks after birth. In grt mice, however, serum concentra-
ions of T4 were very low from neonatal period through adulthood,
nd transient rise in T4 level was not observed [35]. This transient
ise in serum T4 level at about 2 weeks of age in normal mice
as also reported by other investigators [6,8]. These reports and
[ters 559 (2014) 111– 116 115
our results support that adequate thyroid hormone levels in the
neonatal period are important for the development of interneuron
subpopulations in the brain.
Elucidating the mechanism of interneuron differentiation may
increase our understanding of the pathogenic mechanisms of cer-
tain types of intellectual disabilities, such as cretinism.
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